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To determine those factors predictive of the ability to 
both initiate and suppress ventricular tachyarrhythmias 
during electrophysiologic study, the results of pro-
grammed cardiac stimulation were evaluated in 261 pa-
tients: 66 presenting with nonsustained ventricular 
tachycardia, 91 with sustained ventricular tachycardia 
and 104 with ventricular fibrillation. Multivariate logis-
tic regression analysis revealed that the presenting ar-
rhythmia was a potent and independent predictor of the 
ability to provoke ventricular arrhythmias at electro-
physiologic study; a history of myocardial infarction and 
male sex were also significant independent predictors. 
Of patients presenting with sustained ventricular tachy-
cardia, 89% (81 of 91) had inducible ventricular ar-
rhythmias compared with 61 (40 of 66) and 66% (69 of 
104) of patients with nonsustained ventricular tachycar-
dia and ventricular fibrillation, respectively. 
Complete suppression of inducible arrhythmias could 
Early studies (1-4) of patients with ventricular arrhythmias 
defined three types of tachyarrhythmias on the basis of con-
figuration and duration: ventricular fibrillation, "persistent" 
or sustained ventricular tachycardia and "intermittent" or 
nonsustained ventricular tachycardia. "Intermittent" tachy-
cardia was defined variably as comprising runs of ventricular 
tachycardia separated by periods of normal sinus rhythm 
(I), self-terminating within seconds to minutes (2) or four 
or more beats and lasting less than 30 seconds (3,4); "per-
sistent" ventricular tachycardia was then defined as a run 
of tachycardia uninterrupted throughout the period of re-
From the Cardiac Unit, Massachusetts General Hospital, Boston. Mas-
sachusetts 02114. This work was supported in part by Grant 5ROI-HL25992 
from the National Institutes of Health, Bethesda, Maryland. Drs. Garan 
and Ruskin are recipients of an Established Investigatorship (EI 84-209 
and EI81-177, respectively) from the American Heart Association. Dallas, 
Texas. Manuscript received November 20. 1984; revised manuscript re-
ceived February 20, 1985, accepted April I, 1985. 
Address for reprints: Mark H. Schoenfeld, MD. Cardiac Unit, Mas-
sachusetts General Hospital, Boston. Massachusetts 02114. 
CD 1985 by the American College of Cardiology 
be achieved in only 52% (34 of 66) of patients with 
sustained ventricular tachycardia, compared with 73 (~4 
of 33) and 75% (46 of 61) of patients presenting with 
nonsustained ventricular tachycardia and ventricular fi-
brillation, respectively. Multivariate analysis showed that 
the major independent determinants of the ability to 
suppress inducible arrhythmias were the number of drug 
trials performed before electro physiologic study (in-
versely correlated) and the nature of the induced 
arrhythmia. 
The nature of the presenting clinical arrhythmia is, 
therefore, a highly significant and independent predictor 
of the ability to induce ventricular arrhythmias during 
electrophysiologic testing and an important determinant 
ofthe ability to siJppress induced arrhythmias in patients 
with spontaneous ventricular tachyarrhythmias. 
(J Am Coil Cardiol 1985;6:298-306) 
cording (1-4). Programmed electrical stimulation of the 
heart has been utilized recently to initiate and terminate these 
arrhythmias under controlled conditions, and it has been 
demonstrated (5-8) that the suppression of inducible tach-
yarrhythmias during serial antiarrythmic drug testing may 
contribute to a more favorable outcome in patients in whom 
these arrhythmias have occurred spontaneously. 
A number of clinical features, such as the pattern of 
clinical arrhythmia and the presence of coronary artery dis-
ease, have been shown to influence the ability to initiate 
ventricular tachycardia in the electrophysiology laboratory 
(9-12). However, it is not known if these clinical features 
are simply markers of more severe underlying heart disease, 
and, therefore, not independently rela,ted to the outcome of 
electrophysiologic study. In this study, we have analyzed 
multiple clinical, hemodynamic and electrophysiologic vari-
ables in a large group of patients with spontaneously oc-
curring ventricular arrhythmias to determine which, if any, 
of these variables independently influenced the outcome of 
electrophysiologic study. 
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Methods 
Study patients. Comprehensive clinical and electro-
physiologic evaluation was performed in 261 consecutive 
patients with a history of spontaneously occurring, electro-
cardiographically documented ventricular tachyarrhythmias 
not associated with acute myocardial infarction. Of the 261 
patients, 197 were male and 64 female, with an age range 
of 3 to 88 years (mean 57). The underlying cardiac diagnosis 
was atherosclerotic heart disease in 196 patients, cardio-
myopathy in 14 patients, mitral valve prolapse in 11 pa-
tients, other valvular heart disease in 11 patients, congenital 
heart disease (repaired tetralogy of Fallot) in 2 patients, no 
structural heart disease (defined on the basis of normal phys-
ical examination, chest X-ray film, electrocardiogram, 
echocardiogram and coronary angiography) in 12 patients 
and not defined in 15 patients. One hundred seven patients 
were studied because of one or more episodes of cardiac 
arrest, 29 patients because of a history of unexplained syn-
cope and documented nonsustained ventricular tachycardia 
(see later) and the other 78 because of recurrent episodes 
of symptomatic ventricular tachycardia. 
Definition of arrhythmias. Ventricular tachycardia was 
documented in all patients in this series by electrocardi-
ography. A common clinical and laboratory definition of 
ventricular arrhythmias was used in this study. The arrhyth-
mias with which the patients presented were classified as 
non sustained ventricular tachycardia, sustained ventricular 
tachycardia or ventricular fibrillation. Nonsustained ven-
tricular tachycardia was defined as tachycardia that persisted 
for at least 5 beats and reverted spontaneously within 100 
beats to sinus rhythm. Sustained ventricular tachycardia was 
defined as tachycardia that persisted for at least 100 beats 
or that required pacing, drug intervention or external coun-
tershock for termination. In a minority of patients who dem-
onstrated more than one type of clinical arrhythmia, the 
presenting arrhythmia prompting electrophysiologic study 
was defined as the arrhythmia of greatest severity (ventric-
ular fibrillation> sustained ventricular tachycardia> non-
sustained ventricular tachycardia). On the basis of this clas-
sification, 66 patients presented with nonsustained tachycardia, 
91 with sustained ventricular tachycardia and 104 with ven-
tricular fibrillation. 
Electrophysiologic study. All patients gave informed 
consent to intracardiac electrophysiologic evaluation. An-
tiarrhythmic drugs were withheld for at least five half-lives 
before initial electrophysiologic study. Electrode catheters 
were inserted percutaneously and positioned under fluoro-
scopic guidance in the high right atrium, across the tricuspid 
valve in a position that allowed a His bundle deflection to 
be recorded and in the right ventricular apex. Cardiac stim-
ulation was performed with a programmable constant cur-
rent stimulator (Medtronic models 5325 or 2346) that de-
livered rectangular pulses of 2 ms duration at two to five 
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times the diastolic threshold. Stimulation was performed 
from the right ventricular apex in all patients, with the 
introduction of up to two premature ventricular depolari-
zations during normal sinus rhythm and during atrial and 
ventricular pacing at multiple drive cycle lengths, as well 
as three to five beat bursts of rapid ventricular pacing at 
incremental rates until ventricular tachycardia was induced 
or refractoriness encountered. In the last 43 patients, a third 
right ventricular extrastimulus (S4) was introduced if no 
arrhythmia was initiated by double premature extrastimuli. 
The protocol was carried to completion or until the end 
point of programmed cardiac stimulation was achieved, that 
is, the initiation of either sustained ventricular tachycardia 
or the reproducible initiation (;:::three times) of nonsustained 
symptomatic ventricular tachycardia in response to some 
portion of the stimulation protocol. Asymptomatic nons us-
tained ventricular tachycardia was not considered an end 
point in this study. If the initiation of nonsustained ven-
tricular tachycardia resulted in either angina or presyncope, 
programmed cardiac stimulation was stopped without pro-
ceeding to more provocative modes of stimulation. If sus-
tained ventricular tachycardia was induced, extrastimuli or 
bursts of rapid ventricular pacing were applied in an attempt 
to interrupt the arrhythmia. Sustained arrhythmias resulting 
in angina or loss of consciousness were terminated with 
immediate asynchronous external electrical countershock. 
The reproducibility of these sustained arrhythmias or in-
duced ventricular fibrillation was not assessed. In those pa-
tients in whom both nonsustained and sustained ventricular 
tachycardias were induced, sustained ventricular tachycar-
dia was defined as the induced arrhythmia. 
Serial drug testing. In 133 (70%) of the 190 patients 
with inducible ventricular arrhythmias, serial drug testing 
alone was performed in an effort to define a pharmacologic 
regimen that prevented the initiation of ventricular tachy-
cardia by programmed stimulation. We administered an-
tiarrhythmic drugs according to a previously described pro-
tocol, with drug selection on the basis of patient tolerance, 
ease of administration and drug history (12). Drugs were 
evaluated after loading and chronic oral therapy for at least 
48 hours and only after adequate washout (>five half-lives) 
of any previously administered antiarrhythmic drugs had 
occurred. Antiarrhythmic medications were administered in 
the following daily dose ranges (in mg): quinidine sulfate, 
800 to 2,400; procainamide, 3,000 to 8,000; disopyramide, 
300 to 800; phenytoin, 200 to 400; propranolol, 40 to 320; 
mexiletine, 400 to 1,200; tocainide, 1,200 to 2,400; amio-
darone, 400 to 1,200; aprindine, 50 to 150; and lorcainide, 
200 to 300. When obtainable, plasma concentrations of the 
drug were determined at the time of testing. The ventricular 
stimulation protocol employed during serial drug testing was 
identical to that in the control study. Effective medical ther-
apy was defined by the inability to initiate ventricular tachy-
cardia (;:::five beats) by programmed stimulation. 
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Analysis of data. Univariate statistical methods were 
used to screen those clinical variables associated with the 
induction of ventricular arrhythmias by programmed cardiac 
stimulation at initial electrophysiologic study and the ability 
to suppress the induced arrhythmia during serial antiar-
rhythmic testing. The following variables were analyzed: 
age, sex, underlying cardiac diagnosis, presenting clinical 
arrhythmia, reasons for electrophysiologic study (cardiac 
arrest, syncope, recurrent symptomatic arrhythmia, defini-
tion of the mechanisms of a wide complex tachycardia), 
approximate number of symptomatic episodes of tachyar-
rhythmia before electrophysiologic study, total duration of 
arrhythmia from first episode, occurrence of one or more 
myocardial infarctions before study, presence or absence of 
left ventricular aneurysm as determined by ventriculography 
or gated blood pool scan, or both, left ventricular ejection 
fraction defined by ventriculography or gated blood pool 
scan analysis, number of empiric antiarrhythmic drug trials 
before electrophysiologic study and number of coronary 
vessels with significant (>50% narrowing of luminal di-
ameter) stenosis as determined by coronary angiography. 
The time of entry into the study was also evaluated as a 
check both on the potential change in the nature of the 
referred patient group over time and on the refinement of 
electrophysiologic techniques over the study period. In ad-
dition, the subgroup of patients studied with triple premature 
ventricular extrastimuli was compared with the entire patient 
group with regard to the incidence of inducible arrhythmia. 
For the analysis of ability to suppress induced arrhythmia, 
the following variables also were evaluated: nature of the 
induced arrhythmia (nonsustained ventricular tachycardia, 
sustained ventricular tachycardia, ventricular fibrillation), 
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mode of initiation of arrhythmia (number of premature ven-
tricular depolarizations required during sinus rhythm or ven-
tricular pacing or bursts of rapid ventricular pacing) and the 
rate of induced arrhythmia. 
Multivariate methods, logistic regression analysis and 
the Cox model of proportional hazards with the Breslow 
modification (13,14) were then applied to those variables 
determined to have at least marginal (p < 0.10) predictive 
value from the univariate analyses. In this manner, signif-
icant (p < 0.05) independent predictors of both inducibility 
and the ability to fully suppress induced arrhythmias were 
identified. When values for catheterization variables were 
not available because angiographic studies were not under-
taken, patients with missing variables were excluded from 
univariate analysis. Group mean values for such variables 
were computed for all patients in whom these variables were 
not missing and then substituted for the missing values to 
enable a multivariate analysis of the data (8). 
Results 
Clinical characteristics of study patients as a function 
of presenting arrhythmia (Table 1). A significantly greater 
prevalence of non atherosclerotic heart disease was found in 
the group of patients presenting with non sustained ventric-
ular tachycardia than in the other two groups. A greater 
prevalence of previous myocardial infarction and left ven-
tricular aneurysm was found in patients with sustained ven-
tricular tachycardia, although this finding was of borderline 
significance. 
Induction of arrhythmia at initial electrophysiologic 
study. Among 261 patients with previously documented 
Table 1. Clinical Characteristics of 261 Patients on the Basis of Presenting Arrhythmia 
Nonsustained Sustained 
VT VT VF 
(n = 66) (n = 91) (n = 104) 
Cardiac diagnosis* 
Atherosclerotic 39 (59%) 76 (83.5%) 81 (80%) 
Nonatherosc1erotic 27 (50%) 15 (16.5%) 23 (22%) 
Sex 
Male 43 (65%) 77 (85%) 77 (74%) 
Female 23 (35%) 14 (15%) 27 (26%) 
Age (yr) 21 to 28 17 to 80 3 to 75 
(mean 58) (mean 59) (mean 55) 
Myocardial infarction 
None 40 (61%) 34 (37%) 55 (53%) 
Anterior 13 (20%) 28 (31%) 24 (23%) 
Inferior 9 (14%) 23 (25%) 14 (13.5%) 
Both anterior and inferior 4 (6%) 6 (6.5%) 11(10.5%) 
LV aneurysm present 6 (9%) 30 (33%) 15 (14%) 
LV ejection fraction (%) J3 to 90 JO to 79 8 to 81 
(mean 42) (mean 37) (mean 39) 
Previous no. of empiric drug trials o to 6 o to 7 o to 6 
(mean 2.2) (mean 2.9) (mean 2.6) 
*p < 0.05. LV = left ventricular; VF = ventricular fibrillation; VT = ventricular tachycardia. 
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Figure 1. The incidence of inducible ventricular arrhythmias is 
plotted as a function of the clinical arrhythmia with which the 
patients presented. NS-VT = non sustained ventricular tachycar-
dia; SUS-VT = sustained ventricular tachycardia; VF = ventric-
ular fibrillation. 
ventricular tachyarrhythmias, ventricular tachycardia or fi-
brillation was induced at the time of initial electrophysio-
logic study in 190 patients (73%) in the absence of antiar-
rhythmic agents. The arrhythmia induced was non sustained 
ventricular tachycardia in 83 patients, sustained ventricular 
tachycardia in 95 patients and ventricular fibrillation in 12 
patients. Of the 83 patients in whom nonsustained ventric-
ular tachycardia was induced, 10 patients were symptomatic 
with associated presyncope, resulting in termination of the 
study. Induced non sustained ventricular tachycardia was de-
fined as polymorphic in 27 of the 83 patients, with multiple 
episodes initiated in each. This subgroup included 9 patients 
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with previously documented nonsustained ventricular tachy-
cardia, 5 with previous sustained ventricular tachycardia and 
13 with previous ventricular fibrillation. 
Univariate analysis demonstrated that the nature of the 
presenting clinical arrhythmia was a significant determinant 
of the ability to induce ventricular arrhythmias during pro-
grammed cardiac stimulation (Fig. 1). Of 91 patients pre-
senting with sustained ventricular tachycardia, 81 (89%) had 
ventricular arrhythmias initiated at initial electrophysiologic 
study, while only 66 (69 of 104) and 61% (40 of 66) of 
patients presenting with ventricular fibrillation and nonsus-
tained ventricular tachycardia, respectively, had arrhyth-
mias induced (p < 0.001). Of the subgroup of patients 
studied with triple premature ventricular extrastimuli, sim-
ilar rates of induction overall were found for the three types 
of arrhythmias (13 [100%] of 13 patients with sustained 
ventricular tachycardia, II [65%] of 17 patients with ven-
tricular fibrillation and 7 [54%] of 13 patients with non-
sustained ventricular tachycardia; p = 0.016). The char-
acteristics of the induced arrhythmia as a function of the 
presenting arrhythmia are depicted in Table 2. 
Most patients with induced arrhythmia (157 of 190) re-
quired no greater than two ventricular premature depolari-
zations during sinus rhythm or ventricular pacing to initiate 
the arrhythmia. The tachyarrhythmia induced was generally 
non sustained in patients presenting with nonsustained ven-
tricular tachycardia, and was predominantly sustained in 
those presenting with sustained ventricular tachycardia; no 
predominant pattern was evident in patients presenting with 
ventricular fibrillation. Ventricular fibrillation itself was 
provoked rarely during these studies. 
Multivariate logistic regression analysis was then per-
formed to determine whether the presenting arrhythmia was 
Table 2. Characteristics of the Induced Arrhythmia as a Function of the Presenting Arrhythmia 
Presenting Arrhythmia 
Nonsustained Sustained 
VT VT VF 
(n = 40) (n = 81) (n = 69) 
Induced arrhythmia 
Nonsustained VT 29 (72.5%) 20 (24.7%) 34 (49.3%) 
Sustained VT 10 (25.0%) 61 (75.3%) 24 (34.8%) 
VF 1(2.5%) 0(0%) II (15.9%) 
Mode of 
initiation 
I VPD-NSRIVP 7 (17.5%) 17 (21.0%) 7 (10.2%) 
2 VPD-NSRlVP 28 (70.0%) 47 (58.0%) 51 (73.9%) 
3 VPD-NSRIVP 1(2.5%) 4 (4.9%) 2 (2.9%) 
RVP 4 (10.0%) 13 (16.1%) 9 (13.0%) 
Rate of induced 224 (140 to 300) 207 (120 to 300) 245 (140 to 300) 
arrhythmia (beats/min) 
mean (range) 
RVP = rapid ventricular pacing; VPD-NSRIVP = ventricular premature depolarizations during normal 
sinus rhythm or ventricular pacing; VF = ventricular fibrillation; VT = ventricular tachycardia. 
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Figure 2. The probability of inducing ventricular 
arrhythmias in patients with a previously docu-
mented tachyarrhythmia is plotted as a function of 
the presenting clinical arrhythmia, sex of the patient 
and presence of transmural myocardial infarction 
(MI) (none [NO], anterior [ANT] or inferior [INF], 
or both anterior and inferior). F = female; M 
male; other abbreviations as in Figure I. 
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an independent predictor of the ability to induce arrhythmias 
during programmed cardiac stimulation. This analysis iden-
tified three independent predictors of induction: the nature 
of the presenting arrhythmia (p = 0.0015), a history of one 
or more transmural myocardial infarctions (p < 0.001) and 
male sex (p = 0.027). Probability bar graphs demonstrating 
the interaction of these three variables and the likelihood of 
inducing a ventricular tachyarrhythmia during programmed 
cardiac stimulation are shown in Figure 2. 
Suppression of induced arrhythmia. Of 190 patients 
with an arrhythmia induced at initial electrophysiologic study, 
160 patients underwent serial drug testing to determine ther-
apy that would prevent the initiation of ventricular tach-
yarrhythmias during programmed cardiac stimulation. Of 
these 160 patients, ventricular arrhythmias could not be 
provoked on the discharge treatment in 104 patients (65%). 
This included 24 (73%) of 33 patients presenting with non-
sustained ventricular tachycardia and 46 (75%) of 61 pa-
% 100 
80 
~ ~ 60 Figure 3. The incidence of full suppression of inducible ~ 
ventricular arrhythmias is plotted, as a function both of the 40 
presenting clinical arrhythmia (left panel) and of the ven-
tricular arrhythmia induced at initial electrophysiologic study 20 
(right panel). Abbreviations as in Figure I. 
0 
~ ~ -20 
~ 9: ~ -40 
~ 
-60 
tients presenting with ventricular fibrillation, as compared 
with only 34 (52%) of 66 patients presenting with sustained 
ventricular tachycardia (p = 0.016). Thus, the presenting 
arrhythmia proved to be a significant univariate determinant 
of the ability to suppress induced tachyarrhythmias in these 
patients (Fig. 3). When multivariate logistic regression anal-
ysis was performed, however, the presenting arrhythmia did 
not achieve significance in independently predicting 
suppression. The two variables identified as independent 
predictors of suppression were the number of empiric drug 
trials before electrophysiologic study (inversely correlated) 
(p = 0.004) and the nature of the arrhythmia induced at 
initial electrophysiologic study. Induced sustained ventric-
ular tachycardia was harder to suppress (40 of 76 patients; 
53% suppression rate) than induced non sustained ventricular 
tachycardia (56 of 73 patients; 77% suppression rate) or 
induced ventricular fibrillation (8 of II patients; 73% 
suppression rate) (p = 0.015) (Fig. 3). 
P <.02 P <.02 
NS-VT SUS-VT VF NS-VT SUS-VT VF 
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Discussion 
Programmed cardiac stimulation is widely used to select 
antiarrhythmic therapy in patients with recurrent sustained 
ventricular tachycardia, It has been shown that the suppres-
sion of induced arrhythmia during serial electrophysiologic 
testing is predictive of a more favorable long-term outcome 
in patients with these arrhythmias (5-8,15), The role of 
electrophysiologic study in patients with either ventricular 
fibrillation or, in particular, nonsustained ventricular tachy-
cardia, has been less clearly defined (11,12,16-18), We 
examined a large patient group with these arrhythmias and 
evaluated the importance of multiple clinical, hemodynamic 
and electrophysiologic variables in independently defining 
the likelihood of inducing ventricular arrhythmias during 
programmed cardiac stimulation and suppressing induced 
arrhythmias during serial drug study, The identification of 
such patient characteristics and, therefore, of patients who 
are optimal candidates for electrophysiologic studies, has 
become increasingly important, particularly in view of the 
potential morbidity and cost of these procedures (19-21). 
Of particular importance in our study is the finding that in 
patients with previously documented ventricular tachyar-
rhythmias, the pattern of the presenting clinical arrhythmia 
is a potent and independent predictor of the ability to elec-
trically induce ventricular arrhythmias and an important de-
terminant, as well, of the ability to suppress induced 
tachyarrhythmias, 
Influence of the presenting arrhythmia on inducibil-
ity: comparison of nonsustained and sustained ventric-
ular tachycardia. Recent reports (15,22,23) on the appli-
cation of electrophysiologic techniques to the management 
of patients with ventricular tachyarrhythmias have been lim-
ited largely to patients with sustained arrhythmias. In two 
studies (6,7) of relatively few patients with short-lasting, 
self-terminating episodes of ventricular tachycardia, termed 
"nonsustained ventricular tachycardia," initiation of ar-
rhythmia by programmed cardiac stimulation was distinctly 
uncommon. In a larger series of patients, Vandepol et al. 
(9) compared the induction of arrhythmia during pro-
grammed cardiac stimulation in patients with sustained and 
non sustained ventricular tachycardia, finding a higher rate 
of induction in the former group (91 compared with 62%), 
Naccarelli et al. (24), reporting on a smaller selected group 
of patients with ventricular tachycardia and no coronary 
artery disease, found that arrhythmias were induced in 69% 
of patients with sustained ventricular tachycardia but in only 
34% of patients with nonsustained ventricular tachycardia, 
defined as tachycardia that was self-terminating within 30 
seconds. We observed, similarly, a significantly higher in-
cidence of inducible arrhythmias in patients presenting with 
sustained ventricular tachycardia (89%) than in those with 
non sustained ventricular tachycardia (61 % ), The higher in-
duction rates in our study compared with those observed by 
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Naccarelli et al. (24) presumably reflect the more hetero-
geneous nature of the underlying cardiac condition in our 
patient group, Similar rates for induction of arrhythmia in 
patients with nonsustained ventricular tachycardia were re-
ported recently by Buxton et al. (18), 
Comparison of sustained ventricular tachycardia and 
ventricular fibrillation. Several studies (11,12,16) also have 
evaluated the role of e1ectrophysiologic study in the man-
agement of patients resuscitated from cardiac arrest in whom 
sustained ventricular tachycardia or ventricular fibrillation 
was documented at the time of collapse, In the study by 
Josephson et al. (II), 90% of patients with sustained ven-
tricular tachycardia at the time of cardiac arrest had inducible 
arrhythmias as compared with only 43% of patients whose 
initially recorded rhythm was ventricular fibrillation. The 
higher arrhythmia induction rate noted for patients with 
sustained ventricular tachycardia compared with that in pa-
tients presenting with ventricular fibrillation is in accord 
with our observations, The higher induction rate in our group 
with ventricular fibrillation compared with that found by 
Josephson et al. (11 )(61 versus 43%) may reflect differences 
in the nature of the patient group or the stimulation protocol 
used. In a preliminary report, Swerdlow et al. (10) found 
a significant difference in arrhythmia induction rate among 
patients presenting with sustained ventricular tachycardia 
(83%), "unsustained ventricular tachycardia" (defined as 
lasting six beats to 15 seconds) (58%) and ventricular fi-
brillation (33%), although only a few patients were included 
in the latter two groups, 
Independent influence of the presenting arrhyth-
mia. To date, no study has systematically analyzed the 
independent determinants of inducibility of arrhythmias dur-
ing programmed cardiac stimulation, It has been suggested 
that both sustained ventricular tachycardia (as indicated ear-
lier) and the presence of coronary artery disease are posi-
tively correlated with the ability to initiate ventricular tachy-
arrhythmias (9), In the first large study to examine all three 
types of spontaneous tachyarrhythmias, we have demon-
strated that the presenting ventricular arrhythmia is an im-
portant independent predictor of the ability to induce ven-
tricular arrhythmias during programmed cardiac stimulation, 
Compared with other groups, the patients presenting with 
sustained ventricular tachycardia manifested a significantly 
greater prevalence of atherosclerotic heart disease as well 
as a greater tendency for both previous myocardial infarction 
and left ventricular aneurysm, The higher rate of tachycardia 
induction demonstrated in patients presenting with sustained 
ventricular tachycardia may, in part, reflect the presence of 
a stable anatomic substrate for ventricular arrhythmias 
(25-27). Our study, however, demonstrates that the pattern 
of ventricular arrhythmia is not simply a marker of the extent 
of underlying cardiac disease but independently determines 
the likelihood of inducing ventricular arrhythmias during 
programmed cardiac stimulation, 
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Influence of the presenting arrhythmia and other 
variables on the suppression of induced arrhyth-
mias. Our results demonstrate that, as a group, patients 
presenting with sustained ventricular tachycardia have in-
ducible arrhythmias that are more difficult to suppress when 
compared with patients presenting with either nonsustained 
ventricular tachycardia or ventricular fibrillation. A similar 
trend, though for a smaller group of patients without coro-
nary artery disease, was observed by Naccarelli et a1. (24). 
When we analyzed multiple variables in a logistic regression 
model, however, the nature of the presenting arrhythmia 
itself did not independently predict the likelihood of suppres-
sion of induced arrhythmia. Rather, the nature of the induced 
arrhythmia was of greater importance. The significance of 
these findings is not entirely clear. We (17) and others (9,24) 
have observed that the correlation between the presenting 
and induced arrhythmia is great, although not absolute; the 
induced arrhythmia may in part reflect the presenting ar-
rhythmia but apparently carries with it additional significance. 
Our study found that the number of empiric drug trials 
before electrophysiologic study was also a significant in-
dependent predictor of the ability to achieve full arrhythmia 
suppression. Swiryn et a1. (28) similarly found in a smaller 
group of patients presenting only with sustained ventricular 
tachycardia that the number of empiric drug trials before 
study was the one predictor of suppression. In an analysis 
of patients with sustained ventricular tachycardia or ven" 
tricular fibrillation, Swerdlow et a1. (20) identified three 
variables that were independently predictive of drug re-
sponse: fewer coronary arteries with 70% or greater stenosis, 
female sex and fewer episodes of arrhythmias. When a 
predictor function incorporating these variables was applied 
prospectively to a small group of patients, the likelihood of 
benefit from electrophysiologic drug testing was success-
fully predicted. Spielman et a1. (19), using discriminant 
analysis, similarly constructed a predictor function, utilizing 
eight variables that included presence of left ventricular 
aneurysm, left ventricular ejection fraction, age and pres-
ence of coronary artery disease. 
Study limitations. Recently, the administration of triple 
ventricular premature depolarizations during sinus rhythm 
and ventricular pacing has been incorporated into the stim-
ulation protocol of most electrophysiology laboratories. This 
technique has increased the sensitivity of programmed car-
diac stimulation techniques in inducing arrhythmias in pa-
tients with previously documented ventricular tachycardia 
or ventricular fibrillation (29,30). Although this approach 
was not available to the patients evaluated during the early 
part of our study, the influence of the presenting arrhythmia 
on arrhythmia induction was the same for the subgroup of 
patients studied more recently with triple premature extra-
stimuli as for the entire patient group; that is, ventricular 
tachyarrhythmias were most easily induced in patients pre-
senting with sustained ventricular tachycardia. Thus, in-
JACC Vol. 6, No.2 
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dependent of the stimulation mode used and the time at 
which patients were entered into the study, the presenting 
arrhythmia was a significant and independent predictor of 
the ability to induce ventricular arrhythmias during electro-
physiologic testing. 
Recently, several studies (31-34) have shown that stim-
ulation from the left ventricular apex and right ventricular 
outflow tract or during isoproterenol infusion may increase 
the incidence of inducible ventricular arrhythmias in se-
lected patients. Our findings may not be applicable to the 
outcome of electrophysiologic studies using these tech-
niques. Similarly, because our study was limited to patients 
with clinically documented ventricular tachyarrhythmias, 
the determinants of inducibility and suppression of ventric-
ular tachyarrhythmias in patients undergoing programmed 
ventricular stimulation for other indications may be different. 
The definition of nonsustained ventricular tachycardia 
used in our analysis is arbitrary. At present, there is no 
standardization of the definition of electrically induced non-
sustained ventricular tachycardia among various electro-
physiology laboratories. The observed incidence of non-
sustained tachycardia in our series might reflect the end 
points of our stimulation protocol in that more provocative 
stimulation was not undertaken once a reproducible but 
symptomatic nonsustained tachycardia was induced. More 
persistent stimulation or the use of additional stimulation 
sites in such cases might have resulted in a sustained 
tachycardia. 
Electrically induced ventricular tachycardia that is non-
sustained and polymorphic has been observed increasingly 
as more provocative stimulation protocols have evolved in 
various laboratories, and several workers (35-37) have sug-
gested that this response may be a nonspecific finding of 
uncertain clinical significance. We emphasize that all pa-
tients in our study had previously documented sponta-
neously occurring ventricular tachyarrhythmias and that 
nonsustained ventricular tachycardia, when elicited, was a 
highly reproducible end point. In addition, for the subset 
of patients in whom nonsustained tachycardia was poly-
morphic, the presenting arrhythmia was primarily either 
nonsustained ventricular tachycardia or ventricular fibril-
lation; the question of what constitutes a "specific" stim-
ulation response for such arrhythmias remains uncertain 
(12,18). 
The classification of the presenting arrhythmia may, in 
some patients, be difficult. This is true for patients with a 
history of more than one type of ventricular arrhythmia, 
who were arbitrarily identified with the arrhythmia type of 
greatest severity, as well as for patients with out -of-hospital 
cardiac arrest. In this latter group of patients, the definition 
of the presenting arrhythmia may depend on the time after 
collapse at which the patient's rhythm was documented. 
Insofar as it has been recognized that sustained ventricular 
tachycardia often degenerates to ventricular fibrillation 
lACC Vol. 6. No.2 
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(5,11,25), some patients with ventricular fibrillation might 
have been reclassified as having had sustained ventricular 
tachycardia if monitored earlier. Finally, it is possible that 
other unknown variables may prove to have independent 
importance if incorporated into our analysis. 
Conclusion. The question of which patient character-
istics determine optimal candidacy for serial electrophysi-
ologic investigation is one of major clinical importance in 
patients with spontaneously occurring ventricular arrhyth-
mias. This study establishes the presenting arrhythmia as a 
critical and independent determinant of the ability to induce 
arrhythmias in the electrophysiology laboratory. In partic-
ular, patients presenting with sustained ventricular tachy-
cardia are most likely to have inducible ventricular tach-
yarrhythmias. However, these patients are also the least 
likely to attain suppression of induced arrhythmia during 
serial antiarrhythmic testing. Whether early consideration 
of non pharmacologic therapeutic techniques may be appro-
priate in patients with sustained ventricular tachycardia is a 
question that remains to be explored. 
We thank Joanne Melesciuc for excellent secretarial assistance in the prep-
aration of this work and the Massachusetts General Hospital Cardiac Com-
puter Center for computer and statistical assistance. 
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